CA Patent

CA2742659C — Aqueous composition containing follicle-stimulating hormone

Assigned to Aska Pharmaceutical Co Ltd · Expires 2016-09-27 · 10y expired

What this patent protects

The invention provides an aqueous composition comprising follicle-stimulating hormone and a combination of histidine and methionine as a stabilizing agent.

USPTO Abstract

The invention provides an aqueous composition comprising follicle-stimulating hormone and a combination of histidine and methionine as a stabilizing agent.

Drugs covered by this patent

elacestrant-hydrochloride (ELACESTRANT HYDROCHLORIDE)

Patent Metadata

Patent number: CA2742659C
Jurisdiction: CA
Classification: —
Expires: 2016-09-27
Drug substance claim: No
Drug product claim: No
Assignee: Aska Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.